Welcome to episode 046 of Life Sciences 360.

On this episode, Harsh discuss the intersection of luck and preparation in finding opportunities, particularly in the field of cell therapy. Harsh share insights from his conversation with Dr. Jason Bock, founder and CEO of CTMC, about the advancements and challenges in autologous cell therapies. We delve into topics such as manufacturing, strategy formation, and the impact of cell therapy on oncology. 

This episode provides valuable information for anyone interested in the field and invites viewers to explore the possibilities of this groundbreaking technology.

Show notes:

00:00 Introduction
02:40 Autologous Cell Therapies
04:40 Formation of CTMC
08:40 Recognition and Impact
11:48 Challenges in Cell Therapy Manufacturing
15:00 Acquisition of a Facility
17:20 Unexpected Growth
21:49 Houston's Support for Multi-Center Trials
27:52 Conceptualizing Virtual Manufacturing
34:20 Maintaining Focus and Vision

----- 
Links:
* Jason Bock LinkedIn ( https://www.linkedin.com/in/jason-b-bock/ )
* CTMC LinkedIn
(https://www.linkedin.com/company/celltherapymanufacturingcenter/)
*CTMC website (https://ctmc.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/)

*Listen to this episode on the go! 
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

----- 

#Biotech #celltherapy  #MDAnderson #LifeSciences #CellManufacturing #CancerResearch #AdvancedTherapies #BiotechIndustry #MedicalResearch #InnovativeTherapies #BiotechPartnerships #BiotechCareer #Biopharmaceuticals #DigitalQuality #BiotechLeadership #IndustrialManufacturing #healthcareinnovation #MedicineMakers #Biologics #ClinicalResearch #CancerTreatment

For transcripts, check out the podcast website - www.lifesciencespod.com